Stockscreener 앱 받기
3.015
0.66%
-0.025
Nrx Pharmaceuticals Inc 주식(NRXP)의 최신 뉴스
NRX Pharmaceuticals Is Maintained at Buy by D. Boral Capital - Moomoo
NRx Pharmaceuticals, Inc. (NRXP) Latest Stock News & Headlines - Yahoo Finance
Amid ketamine shortages, NRx begins making a preservative-free U.S. version - Stock Titan
NRx Pharmaceuticals (Nasdaq:NRXP) Announces Initiation of Commercial Manufacturing for Preservative Free Ketamine - Yahoo Finance
NRXP Stock Price, Quote & Chart | NRX PHARMACEUTICALS INC (NASDAQ:NRXP) - ChartMill
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Sees Large Growth in Short Interest - MarketBeat
NRx Pharmaceuticals, Inc. (NRXP) surpasses Q4 earnings estimates - MSN
NRx Reports FDA Feedback, Progress on Ketamine Application - MyChesCo
Equities Analysts Offer Predictions for NRXP Q1 Earnings - MarketBeat
Analysts Offer Insights on Healthcare Companies: Dogwood Therapeutics (DWTX), NRX Pharmaceuticals (NRXP) and Immuneering (IMRX) - The Globe and Mail
NRXP Forecast, Price Target & Analyst Ratings | NRX PHARMACEUTICALS INC (NASDAQ:NRXP) - ChartMill
NRx Pharmaceuticals (NASDAQ:NRXP) Earns "Buy" Rating from HC Wainwright - MarketBeat
NRx Pharmaceuticals (NASDAQ:NRXP) Price Target Raised to $49.00 at Ascendiant Capital Markets - MarketBeat
H.C. Wainwright reiterates NRx Pharmaceuticals stock rating on FDA progress - Investing.com
H.C. Wainwright reiterates NRx Pharmaceuticals stock rating on FDA progress By Investing.com - Investing.com India
NRx Pharmaceuticals gets FDA approval for suitability petition of Ketafree - MSN
New to The Street Broadcasts Show #746 Tonight on Bloomberg Television 6:30PM EST Featuring NRx Pharma (NASDAQ:NRXP), Performance Golf, Lost Soldier Oil & Gas, Dr. Lee Gause, and CISO Global - Scott Coop
Positive FDA Response on Preservative-Free Ketamine After President Trump Orders Accelerated Approval for Psychedelic Medication Developers Including NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) - Barchart.com
NRx Pharmaceuticals (NASDAQ: NRXP) Receives Positive FDA Review Letter Supporting Ketamine ANDA Progress - Barchart.com
NRx Pharmaceuticals receives FDA positive review for ketamine ANDA By Investing.com - Investing.com India
NRXP (NRX Pharmaceuticals Inc.) posts wider than expected Q4 2025 loss even as shares rise modestly today.Earnings Season - Cổng thông tin điện tử tỉnh Tây Ninh
NRX Pharmaceuticals (NRXP) Sector Rotation | Q4 2025: Earnings Fall ShortProfessional Trade Ideas - Xã Thanh Hà
NRX Pharmaceuticals, Inc. Common Stock (NRXP) Stock Price Today & Analysis - Gotrade
Positive FDA Response on Preservative-Free Ketamine After - openPR.com
NRx Pharmaceuticals receives FDA positive review for ketamine ANDA - Investing.com
NRx Pharmaceuticals Reports Positive FDA Office of Generic Drugs Feedback on Preservative-Free Ketamine Program - The Manila Times
NRXP Financials: Income Statement, Balance Sheet & Cash Flow | Nrx Pharmaceuticals Inc - Stock Titan
FinancialContentPresidential Executive Order to Accelerate Approval of Psychedelic Medications; Those Being Developed by NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) - FinancialContent
NRXP Ownership | NRX PHARMACEUTICALS INC (NASDAQ:NRXP) - ChartMill
NRx Pharmaceuticals Appoints Glenn Tyson as Chief Commercial Officer - MyChesCo
NRx Pharmaceuticals, Inc. (NRXPW) Stock Price, News, Quote & History - Yahoo Finance
NRx Re-Files FDA Application for Preservative-Free IV Ketamine - MSN
NRx Pharmaceuticals Welcomes Presidential Initiative to Accelerate Approval of Psychedelic Medications to Treat Depression, PTSD, and Suicidality - Investing News Network
NRx Pharmaceuticals (NASDAQ: NRXP) Supports Executive Order To Accelerate Psychedelic Drug Development - The Globe and Mail
NRx Pharmaceuticals welcomes the newly-signed Executive Order - TipRanks
NRx Pharmaceuticals' (NRXP) Buy Rating Reiterated at D. Boral Capital - MarketBeat
NRx Pharmaceuticals (Nasdaq:NRXP) Welcomes Presidential Initiative to Accelerate Approval of Psychedelic Medications to Treat Depression, PTSD, and Suicidality - ChartMill
NRx says FDA finds no bioequivalence issues in ketamine filing - MSN
NRx Pharmaceuticals Advances Robotic-Enabled Transcranial Magnetic Stimulation Combined with Neuroplastic Therapy for Military and First Responder Applications - Investing News Network
User - The Chronicle-Journal
NRx Pharmaceuticals forms defense R&D subsidiary By Investing.com - Investing.com Australia
AI-Driven Neurotechnology Expansion as FDA Path Clears and New Defense Initiative Emerges for NRx Pharmaceuticals (N A S D A Q: NRXP) - WFMZ.com
NRx Pharmaceuticals (NASDAQ: NRXP) Forms NRx Defense Systems Subsidiary to Advance Neuroplastic Therapies for Military and Government Applications - Barchart
0.78%
3.01%
자본화:
|
볼륨(24시간):